Therefore, our results demonstrated that genetic downregulation of NEDD8 has anti-ESCC effects and mechanisms similar to those of MLN4924, and confirmed NEDD8 as a therapeutic target in ESCC. Here, NEDD8 is linked to esophageal squamous cell carcinoma.